These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15077165)

  • 1. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth.
    Guerrero C; Martín-Encabo S; Fernández-Medarde A; Santos E
    Oncogene; 2004 Jun; 23(28):4885-93. PubMed ID: 15077165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
    Martín-Encabo S; Santos E; Guerrero C
    Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis.
    Ohba Y; Ikuta K; Ogura A; Matsuda J; Mochizuki N; Nagashima K; Kurokawa K; Mayer BJ; Maki K; Miyazaki J; Matsuda M
    EMBO J; 2001 Jul; 20(13):3333-41. PubMed ID: 11432821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation.
    Jacobsen K; Groth A; Willumsen BM
    Oncogene; 2002 May; 21(19):3058-67. PubMed ID: 12082537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of Rap1, antagonist to ras, by Crk-C3G].
    Hattori S; Matsuda M
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1414-21. PubMed ID: 9309134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1.
    Ishimaru S; Williams R; Clark E; Hanafusa H; Gaul U
    EMBO J; 1999 Jan; 18(1):145-55. PubMed ID: 9878058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Crk signaling pathway contributes to the bombesin-induced activation of the small GTPase Rap1 in Swiss 3T3 cells.
    Posern G; Rapp UR; Feller SM
    Oncogene; 2000 Dec; 19(54):6361-8. PubMed ID: 11175351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crk activation of JNK via C3G and R-Ras.
    Mochizuki N; Ohba Y; Kobayashi S; Otsuka N; Graybiel AM; Tanaka S; Matsuda M
    J Biol Chem; 2000 Apr; 275(17):12667-71. PubMed ID: 10777559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene.
    Yamashita A; Hakura A; Inoue H
    Oncogene; 1999 Aug; 18(34):4777-87. PubMed ID: 10490811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3G is required for c-Abl-induced filopodia and its overexpression promotes filopodia formation.
    Radha V; Rajanna A; Mitra A; Rangaraj N; Swarup G
    Exp Cell Res; 2007 Jul; 313(11):2476-92. PubMed ID: 17475248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway.
    Hirota T; Irie K; Okamoto R; Ikeda W; Takai Y
    Oncogene; 2005 Mar; 24(13):2229-35. PubMed ID: 15688018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3G, a guanine nucleotide exchange factor bound to adapter molecule c-Crk, has two alternative splicing forms.
    Zhai B; Huo H; Liao K
    Biochem Biophys Res Commun; 2001 Aug; 286(1):61-6. PubMed ID: 11485308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3G silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival.
    Maia V; Sanz M; Gutierrez-Berzal J; de Luis A; Gutierrez-Uzquiza A; Porras A; Guerrero C
    Cell Signal; 2009 Jul; 21(7):1229-35. PubMed ID: 19324082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
    Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK
    Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.